Synthesis and biological evaluation of (E)-cinnamic acid, (E)-2-styrylthiazole and (E)-2-[2-(naphthalen-1-yl)vinyl]thiazole derivatives
dc.contributor.author | Olawode, Emmanuel O. | |
dc.contributor.author | Tandlich, Roman | |
dc.contributor.author | Prinsloo, Earl | |
dc.contributor.author | Isaacs, Michelle | |
dc.contributor.author | Hoppe, Heinrich | |
dc.contributor.author | Seldon, Ronnett | |
dc.contributor.author | Warner, Digby F. | |
dc.contributor.author | Steenkamp, Vanessa | |
dc.contributor.author | Kaye, Perry T. | |
dc.date.accessioned | 2017-11-20T13:18:30Z | |
dc.date.available | 2017-11-20T13:18:30Z | |
dc.date.issued | 2017-04 | |
dc.description.abstract | Cinnamyl- and thiazole-based compounds have been shown to exhibit diverse medicinal properties and a series of twelve (E)-2-styrylthiazole and (E)-2-[(naphthalen-1-yl)vinyl]thiazole derivatives, which are conjugates of both systems and which satisfy the “Lipinski rule of 5”, have been synthesised and subjected to in vitro biological screening. While insignificant inhibition (60-98% viability at 10 μM) of HeLa (cervical cancer) cells was noted, all five of the (E)-2-[naphthalen-1- yl)vinyl]thiazole derivatives proved remarkably active against SH-SY5Y (neuroblastoma) cells with IC50 values ranging from 2.09 to 8.64 μM. Two of the seven (E)-2-styrylthiazoles were found to be moderately active (with IC50 values of 10.8 and 11.7 mM), whereas the remaining five analogues exhibit significant proliferation of SH-SY5Y cells (with IC50 values of 180-1000 mM). The results warrant further studies on the effects of styrylthiazoles on the differentiation and extension of SH-SY5Y cells in order to assess their activity in neurological degenerative diseases. | en_ZA |
dc.description.department | Pharmacology | en_ZA |
dc.description.librarian | am2017 | en_ZA |
dc.description.sponsorship | Rhodes University for a bursary (E. O. O) and Rhodes University and the South African Medical Research Council (MRC) for generous financial support. This research project was supported by the South African Medical Research Council (MRC) with funds from National Treasury under its Economic Competitiveness and Support Package. The xCELLigence Real-Time Cell Analyzer SP Station was supported through the National Research Foundation (NRF) - Department of Science & Technology (DST) Research Infrastructure Support Programme (National Nanotechnology Equipment Programme) grant. | en_ZA |
dc.description.uri | http://www.arkat-usa.org | en_ZA |
dc.identifier.citation | Olawode, E.O. et al. 2017, 'Synthesis and biological evaluation of (E)-cinnamic acid, (E)-2-styrylthiazole and (E)-2-[2-(naphthalen-1-yl)vinyl]thiazole derivatives', Arkivoc, Part vi. pp. 284-296. | en_ZA |
dc.identifier.issn | 1551-7012 (print) | |
dc.identifier.issn | 1551-7004 (online) | |
dc.identifier.other | 10.3998/ark.5550190.p009.905 | |
dc.identifier.uri | http://hdl.handle.net/2263/63240 | |
dc.language.iso | en | en_ZA |
dc.publisher | Michigan Publishing | en_ZA |
dc.rights | © ARKAT-USA, Inc. Published with a Creative Commons Attribution Non-Commercial License. | en_ZA |
dc.subject | Synthesis | en_ZA |
dc.subject | Cinnamic acids | en_ZA |
dc.subject | Styrylthiazoles | en_ZA |
dc.subject | 2-[2-(Naphthalen-1-yl)vinyl]thiazoles | en_ZA |
dc.subject | Biological activity | en_ZA |
dc.subject | Peptides | en_ZA |
dc.subject | Plasmodium falciparum | en_ZA |
dc.title | Synthesis and biological evaluation of (E)-cinnamic acid, (E)-2-styrylthiazole and (E)-2-[2-(naphthalen-1-yl)vinyl]thiazole derivatives | en_ZA |
dc.type | Article | en_ZA |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.75 KB
- Format:
- Item-specific license agreed upon to submission
- Description: